IRIDEX vs MedScout
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
IRIDEX
This application provides information on advanced laser-based medical systems for ophthalmology. It focuses on proprietary MicroPulse technology for treating sight-threatening eye conditions like glaucoma and diabetic macular edema.
- Laser-based medical systems
- MicroPulse technology
- Treatment for glaucoma
- Treatment for diabetic macular edema
- Retinal disease treatment
Read full descriptionHide full description
IRIDEX is a worldwide leader in developing innovative and versatile laser-based medical systems for the ophthalmology market. The Company’s proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit http://www.iridex.com/.
MedScout
This app provides a mobile web interface for managing business-related information. It offers a streamlined way to access and interact with data on the go. Designed for efficiency, it aims to enhance productivity for professionals.
- Mobile web access
- Business information management
- Streamlined data interaction
- Enhanced productivity
- On-the-go access
Read full descriptionHide full description
MedScout is built for MedTech teams who need the best insights available. It turns billions of claims into ranked, territory-specific opportunities, maps the referral relationships behind them, and profiles every provider, from procedure volume and payer mix to industry payments. Office schedules, optimized routes, and automatic CRM sync keep reps face-to-face instead of buried in spreadsheets. Scout AI can find providers near you or anywhere in your territory based on procedures, diagnoses, payer mix, specialty, site of care, referrals and more.
Screenshots
Verdict
The clearest difference is update cadence: MedScout at monthly against IRIDEX's every 6 months. MedScout also leads on ratings volume (10 vs 2). On price, rating, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for IRIDEX against 5.0 for MedScout. That said, the two scores are not equally well evidenced: MedScout has 10 ratings behind it against 2, so its average is the more settled of the two.
IRIDEX ships an update every 6 months, MedScout monthly. The most recent releases landed on October 11, 2026 and October 9, 2026 respectively.
| Parameter | IRIDEX | MedScout |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (2 ratings) | 5.0 (10 ratings) |
| Number of ratings | 2 | 10 — better |
| Update frequency | Every 6 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 14.0 — better | 15.1 |
| Further details — not scored | ||
| Size | 109 MB | 120 MB |
| Age rating | 4+ | 17+ |
| Developer | bigtincan mobile pty ltd | Medscout |
Customer experience
IRIDEX
MedScout
In-app purchases
IRIDEX
No in-app purchases
MedScout
No in-app purchases
